Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 3Hematologic Neoplasms 3Myelodysplastic Syndromes 2Triple Negative Breast Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic-Myeloproliferative Diseases 1Mycoses 1Mucormycosis 1Glioblastoma 1Genetic Predisposition to Disease 1Candidiasis 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1Brain Neoplasms 1Aspergillosis 1

Interventions

posaconazole 1liposomal amphotericin B 1isavuconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mucormycosis × posaconazole × 1 year × Clear all
NCT07185503 2025-09-22

Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and Safety

Institute of Hematology & Blood Diseases Hospital, China

Recruiting
60 enrolled
Other hematologic neoplasm

Mucormycosis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡